Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study. Maclean R, Chen Y, Lumbers RT, Shah AD, et al. Heart 2025 Apr 18:heartjnl-2024-325132. doi: 10.1136/heartjnl-2024-325132.

Read + Share

Amedeo Smart

Independent Medical Education

Maclean R, Chen Y, Lumbers RT, Shah AD, et al. Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study. Heart 2025 Apr 18:heartjnl-2024-325132. doi: 10.1136/heartjnl-2024-325132.
PMID: 40250982